AAAAAA

   
Results: 1-10 |
Results: 10
IN-VIVO EFFICACY OF SM-20302, A GP IIB IIIA RECEPTOR ANTAGONIST, CORRELATES WITH EX-VIVO PLATELET INHIBITION IN HEPARINIZED BLOOD BUT NOT IN CITRATED BLOOD/
Authors: REBELLO SS HUANG JB SAITO K LUCCHESI BR
Citation: Ss. Rebello et al., IN-VIVO EFFICACY OF SM-20302, A GP IIB IIIA RECEPTOR ANTAGONIST, CORRELATES WITH EX-VIVO PLATELET INHIBITION IN HEPARINIZED BLOOD BUT NOT IN CITRATED BLOOD/, Arteriosclerosis, thrombosis, and vascular biology, 18(6), 1998, pp. 954-960
CORRELATION BETWEEN THE IN-VIVO EFFICACY OF GPIIB IIIA RECEPTOR ANTAGONISTS AND EX-VIVO PLATELET INHIBITION - ROLE OF CALCIUM/
Authors: HUANG J REBELLO SS FAUL JD LUCCHESI BR
Citation: J. Huang et al., CORRELATION BETWEEN THE IN-VIVO EFFICACY OF GPIIB IIIA RECEPTOR ANTAGONISTS AND EX-VIVO PLATELET INHIBITION - ROLE OF CALCIUM/, The FASEB journal, 12(4), 1998, pp. 1113-1113
PHARMACOKINETICS AND PHARMACODYNAMICS OF SM-20302, A GPIIB IIIA RECEPTOR ANTAGONIST, IN ANESTHETIZED DOGS/
Authors: REBELLO SS HUANG JB SHIN WJ SAITO K KANEKO M SAITOH Y LUCCHESI BR
Citation: Ss. Rebello et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF SM-20302, A GPIIB IIIA RECEPTOR ANTAGONIST, IN ANESTHETIZED DOGS/, Journal of cardiovascular pharmacology, 32(3), 1998, pp. 485-494
CVS-1123, A DIRECT THROMBIN INHIBITOR, PREVENTS OCCLUSIVE ARTERIAL AND VENOUS THROMBOSIS IN A CANINE MODEL OF VASCULAR INJURY
Authors: REBELLO SS MILLER BV BASLER GC LUCCHESI BR
Citation: Ss. Rebello et al., CVS-1123, A DIRECT THROMBIN INHIBITOR, PREVENTS OCCLUSIVE ARTERIAL AND VENOUS THROMBOSIS IN A CANINE MODEL OF VASCULAR INJURY, Journal of cardiovascular pharmacology, 29(2), 1997, pp. 240-249
TP-9201, A GLYCOPROTEIN IIB IIIA PLATELET RECEPTOR ANTAGONIST, PREVENTS RETHROMBOSIS AFTER SUCCESSFUL ARTERIAL THROMBOLYSIS IN THE DOG/
Authors: REBELLO SS DRISCOLL EM LUCCHESI BR
Citation: Ss. Rebello et al., TP-9201, A GLYCOPROTEIN IIB IIIA PLATELET RECEPTOR ANTAGONIST, PREVENTS RETHROMBOSIS AFTER SUCCESSFUL ARTERIAL THROMBOLYSIS IN THE DOG/, Stroke, 28(9), 1997, pp. 1789-1796
ANTITHROMBOTIC EFFICACY OF A RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5) IN CANINE MODELS OF THROMBOSIS AFTER SINGLE SUBCUTANEOUS ADMINISTRATION
Authors: REBELLO SS BLANK HS ROTE WE VLASUK GP LUCCHESI BR
Citation: Ss. Rebello et al., ANTITHROMBOTIC EFFICACY OF A RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5) IN CANINE MODELS OF THROMBOSIS AFTER SINGLE SUBCUTANEOUS ADMINISTRATION, The Journal of pharmacology and experimental therapeutics, 283(1), 1997, pp. 91-99
SIGNIFICANCE OF FACTOR XA INHIBITION IN A CANINE MODEL OF CORONARY-THROMBOSIS - EFFECTS OF RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5)
Authors: REBELLO SS LUCCHESI BR
Citation: Ss. Rebello et Br. Lucchesi, SIGNIFICANCE OF FACTOR XA INHIBITION IN A CANINE MODEL OF CORONARY-THROMBOSIS - EFFECTS OF RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5), The FASEB journal, 10(3), 1996, pp. 2504-2504
THROMBOSTATIN - IN-VIVO CLEARANCE AND EFFECT OF THIS THROMBIN RECEPTOR INHIBITOR
Authors: HASAN AA REBELLO SS WAHL R FISHER SJ LUCCHESI BR SCHMAIER AH
Citation: Aa. Hasan et al., THROMBOSTATIN - IN-VIVO CLEARANCE AND EFFECT OF THIS THROMBIN RECEPTOR INHIBITOR, Circulation, 94(8), 1996, pp. 1339-1339
RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5), A SELECTIVE FACTOR XA INHIBITOR, PREVENTS CANINE CORONARY-ARTERY THROMBOSIS
Authors: REBELLO SS LUCCHESI BR
Citation: Ss. Rebello et Br. Lucchesi, RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5), A SELECTIVE FACTOR XA INHIBITOR, PREVENTS CANINE CORONARY-ARTERY THROMBOSIS, Circulation, 94(8), 1996, pp. 1562-1562
ORALLY EFFECTIVE CVS-1123 PREVENTS CORONARY-ARTERY THROMBOSIS IN THE CONSCIOUS DOG
Authors: COUSINS GR FRIEDRICHS GS SUDO Y REBELLO SS ROTE WE VLASUK GP NOLAN TG MENDOZA C LUCCHESI BR
Citation: Gr. Cousins et al., ORALLY EFFECTIVE CVS-1123 PREVENTS CORONARY-ARTERY THROMBOSIS IN THE CONSCIOUS DOG, Circulation, 94(7), 1996, pp. 1705-1712
Risultati: 1-10 |